A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
Type 2 diabetes results when the body does not produce enough insulin to regulate blood
sugar. This study is designed to measure the effect of vildagliptin on the maximum insulin
secretion by the pancreas.